Protective effect of a GRK5 polymorphismon heart failure and its interaction with &bgr;β-adrenergic receptor antagonists

Author： Eijgelsheim Mark   Visser Loes E   Uitterlinden Andréé G   Stricker Bruno H Ch  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.9, Iss.10, 2008-10, pp. : 1551-1555

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

GRK5 Gln41Leu polymorphism is not associated with sensitivity to &bgr;β1-adrenergic blockade in humans

By Kurnik Daniel   Cunningham Andrew J   Sofowora Gbenga G   Kohli Utkarsh   Li Chun   Friedman Eitan A   Muszkat Mordechai   Menon Usha B   Wood Alastair JJ   Stein C Michael  

Pharmacogenomics, Vol. 10, Iss. 10, 2009-10 ,pp. : 1581-1587

Future Medicine

Access to resources Recommend Favorite

Research Highlights: &bgr;1- and α2C-adrenergic receptor polymorphisms and the antiarrhythmic effect of bucindolol in heart failure with reduced ejection fraction

By Lymperopoulos Anastasios   Negussie Shmuel   Walklett Karlee  

Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. : 1545-1549

Future Medicine

Access to resources Recommend Favorite

Heart failure and endothelin receptor antagonists

By Miyauchi T.   Goto K.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 5, 1999-05 ,pp. : 210-217

Elsevier

Access to resources Recommend Favorite

Vasopressin receptor antagonists in heart failure

By Thibonnier M.  

Current Opinion in Pharmacology, Vol. 3, Iss. 6, 2003-12 ,pp. : 683-687

Elsevier

Access to resources Recommend Favorite

Ligand and Structure Based Models for the Identification of Beta 2 Adrenergic Receptor Antagonists

By  

Current Computer - Aided Drug Design, Vol. 11, Iss. 3, 2015-09 ,pp. : 222-236

Bentham Science Publishers

Access to resources Recommend Favorite